Three months ago, the reported enrollment was 119 and that was in two years, and that means the average enrollment per quarter was less than 20. This time the number was 162, up 43 in one quarter, or up more than 100% in speed. If this trend keeps going, enrollment will be over 300 this year, and will be completed by the second half of next year.
I would say two years the most. Don't forget that CYCC has the special agreement with the FDA that once the data of the trial matches what the agency is looking for, the drug will be approved, unlike SNSS' which will have to go through a year-long applying process..